Tramadol is an opioid with a second mechanism. The FDA’s label describes it as an opioid agonist that also blocks the reuptake of norepinephrine and serotonin [1]. That second mechanism is why it carries two warnings most opioids do not. One is seizures. The other is serotonin syndrome [1]. It carries the usual opioid boxed warnings as well. They cover addiction, breathing, accidental ingestion, mixing with other depressants, and use during pregnancy [1]. And it is barred for young children, as codeine is, for the same reason [1]. It sat outside the federal schedules for years. Since 2014 it has been a Schedule IV controlled substance [5].
This page is the hub for tramadol on this site. It covers what the drug is and how it came to be scheduled, and whether it is addictive. It covers the seizure and serotonin syndrome warnings in the label’s words, and why children cannot take it. It covers what an overdose looks like and what naloxone does and does not do here. It covers withdrawal in outline, how long tramadol stays in the body in the only form a federal source supports, and how treatment works. It names no amount and no schedule. Our hub on prescription drug addiction covers the wider class.
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
What Tramadol Is, and How It Came to Be Scheduled
The label says the drug’s mode of action is not completely understood. Its pain relief is believed to come from two things at once. One is binding to mu-opioid receptors. The other is weak blocking of the reuptake of norepinephrine and serotonin [1]. Its opioid activity comes from the parent drug and from a metabolite the label calls M1. M1 binds the receptor more tightly [1]. Tramadol tablets are indicated in adults for pain severe enough to require an opioid, where other treatments are inadequate [1]. The label’s limit on that use is the same as every opioid’s. The risks of addiction, abuse, misuse, overdose and death can occur at any amount or duration. So opioid pain medicines are reserved for patients for whom other options do not work [1].
MedlinePlus describes the immediate-release tablets and solution as a short-term treatment for severe pain in people expected to need an opioid. It describes the extended-release forms as treatment for severe, persistent pain around the clock [2]. Its brand-name list marks Ultram, Ultram ER, Ultracet, Rybix and Ryzolt as no longer on the market, with Conzip, Qdolo and Seglentis still sold [2]. NIDA describes tramadol as a prescription opioid pain reliever used for mild to moderate pain [4].
The scheduling has a date. In a final rule published on July 2, 2014, the Drug Enforcement Administration placed the drug, including its salts and isomers, into Schedule IV of the Controlled Substances Act. The rule took effect on August 18, 2014 [5]. The DEA’s scheduling page lists tramadol among the Schedule IV drugs today, alongside Xanax, Valium, Ativan and Ambien [6]. The label and NIDA both say Schedule IV [1][4]. In the DEA’s definition, Schedule IV drugs have a low potential for abuse and low risk of dependence relative to Schedule III [6]. That is a legal category. It is not a safety rating, and the rest of this page is why.
Is Tramadol Addictive? What the Label and NIDA Say
The label answers with its first boxed warning. Tramadol exposes users to the risks of addiction, abuse and misuse, which can lead to overdose and death [1]. It tells prescribers to assess each patient’s risk before prescribing and to monitor regularly [1]. The risk of addiction in any individual is unknown, the label says. But it can occur in patients who are prescribed tramadol appropriately [1]. The label keeps the terms apart. Misuse is the intentional use of a drug for a medical purpose in a way other than prescribed, or by someone it was not prescribed for. Abuse is the intentional, non-medical use of a drug, even once, for its desirable effects. Addiction is a cluster of behaviors and physical signs. It may include a strong desire to take the drug, trouble controlling use, continuing despite harm, and putting drug use ahead of other obligations [1]. Tolerance is a reduced response after repeated use. Physical dependence is an adaptation that shows itself as withdrawal when the drug is stopped abruptly or cut sharply [1].
The label names who is at higher risk: people with a personal or family history of substance abuse, including drug or alcohol abuse or addiction, or of mental illness such as major depression [1]. It also carries a warning that is unusual in its bluntness. Do not prescribe the drug for patients who are suicidal or addiction-prone, the label says. Consider non-narcotic pain relievers for patients who are suicidal or depressed [1].
NIDA says people who use tramadol may develop an opioid use disorder [4]. It describes misuse as taking the drug in a way or amount other than prescribed, taking it without a prescription, or taking it with other drugs to boost the intoxicating effects [4]. MedlinePlus says it to the person taking it. Tramadol may be habit forming, especially with prolonged use [2]. Your doctor needs to know if you or anyone in your family has drunk large amounts of alcohol, used street drugs, overused prescription drugs, had an overdose, or had depression or another mental illness. The risk of overusing the drug is greater with any of those [2].
The Seizure Warning, and the Serotonin Syndrome Warning
These two warnings are the ones that make tramadol different, and the label words them carefully.
Seizures. Seizures have been reported in patients receiving tramadol within the range the label allows [1]. Postmarketing reports indicate the risk is increased at amounts above that range [1]. The label says using the drug with certain other drugs raises the seizure risk. It names SSRI antidepressants. It names tricyclic antidepressants and other tricyclic compounds such as cyclobenzaprine and promethazine. It names other opioids, MAO inhibitors, neuroleptics, and other drugs that lower the seizure threshold [1]. The risk may also be higher in people with epilepsy or a history of seizures. It may be higher with a known risk for seizure, such as head trauma, metabolic disorders, alcohol and drug withdrawal, or infections of the central nervous system [1]. One sentence in that passage matters for an emergency. In tramadol overdose, the label says, giving an opioid reversal agent such as naloxone or nalmefene may increase the risk of seizures [1].
Serotonin syndrome. Cases of serotonin syndrome, a potentially life-threatening condition, have been reported with the drug. Most came when it was used with other drugs that act on serotonin [1]. The label’s list of those drugs is long. It includes SSRIs, SNRIs, tricyclic antidepressants and triptans. It includes certain anti-nausea drugs, mirtazapine, trazodone and certain muscle relaxants. And it includes drugs that impair the breakdown of serotonin, such as MAO inhibitors and the antibiotic linezolid [1]. The label says this may occur within the range it allows [1]. The symptoms come in four groups. Mental changes: agitation, hallucinations, coma. Body-control changes: fast heartbeat, unstable blood pressure, high temperature. Muscle and nerve signs: overactive reflexes, poor coordination, rigidity. And stomach symptoms: nausea, vomiting, diarrhea [1]. Onset generally occurs within several hours to a few days of combined use, but may occur later. The label’s instruction is to stop the drug if serotonin syndrome is suspected [1]. MedlinePlus puts the same cluster in its emergency list: agitation, hallucinations, fever, sweating, confusion, fast heartbeat, shivering, severe muscle stiffness or twitching, loss of coordination, or diarrhea [2].
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
Why Tramadol Is Contraindicated in Children, and the Other Boxed Warnings
The label’s boxed warning says life-threatening respiratory depression and death have occurred in children who received the drug. Some of the reported cases followed tonsillectomy or adenoidectomy. In at least one case the child had evidence of being an ultra-rapid metabolizer because of a CYP2D6 variant [1]. The label explains that tramadol and codeine are both subject to variability in metabolism based on CYP2D6 genotype. That can lead to increased exposure to an active metabolite [1]. Our hub on codeine addiction covers the other drug in that pair. The label draws the same three lines for tramadol. It is contraindicated for all children younger than 12 [1]. It is contraindicated for post-operative pain in patients younger than 18 after tonsillectomy or adenoidectomy [1]. And it is to be avoided in adolescents aged 12 to 18 with other risk factors for slowed breathing, unless the benefits outweigh the risks. The label’s examples are sleep apnea, obesity, severe lung disease and other drugs that slow breathing [1]. MedlinePlus says it plainly. Tramadol should never be used to treat pain in children younger than 12, or after surgery to remove the tonsils or adenoids in anyone younger than 18 [2].
The rest of the boxed warning is the opioid class’s. Serious, life-threatening or fatal respiratory depression may occur, especially when treatment starts or the amount is increased [1]. Accidental ingestion, especially by a child, can result in a fatal overdose [1]. Using an opioid with benzodiazepines or other central nervous system depressants, including alcohol, may result in profound sedation, respiratory depression, coma and death [1]. Extended use during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated [1]. And one warning is specific to the drug’s chemistry. Starting or stopping drugs that induce or inhibit the liver enzymes CYP3A4 and CYP2D6 has complex effects. Using them with tramadol requires careful thought about the parent drug and its active metabolite [1]. MedlinePlus says the breathing risk is highest during the first 24 to 72 hours of treatment and any time the amount is increased. Slowed breathing, long pauses between breaths or shortness of breath call for immediate medical help [2].
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
Help for tramadol dependence in Florida
The Recovery Village Umatilla is our campus in Umatilla, Florida, and its own page cards medical detox, inpatient treatment for substance abuse, inpatient rehab for mental health, partial hospitalization programming, outpatient programming and aftercare planning. Its inpatient card says clients who have completed detox begin the work of recovery in a safe environment, and whether a person needs that level or a lighter one is decided at the assessment.
See treatment options in Florida
Verify your insurance
The Recovery Village Umatilla is part of our family of treatment centers. See the Recovery Village Umatilla campus.
Tramadol Overdose: Signs, Naloxone and What to Do
The label’s description is direct. Acute overdose with tramadol can show as respiratory depression, sleepiness progressing to stupor or coma, limp muscles, cold and clammy skin, and constricted pupils [1]. In some cases there is fluid in the lungs, slow heartbeat, low blood pressure, low blood sugar, airway obstruction, atypical snoring, seizures and death [1]. Deaths due to overdose have been reported with abuse and misuse of the drug. A review of case reports indicates the risk of a fatal overdose is further increased when it is abused with alcohol or other depressants, including other opioids [1]. MedlinePlus’s instruction for any overdose is to call 911 if the person has collapsed, had a seizure, has trouble breathing or cannot be woken [2].
Naloxone needs a longer sentence here than on most opioid pages. NIDA says too much of the drug can slow breathing so much that the person suffocates. An overdose can be reversed if a reversal medication such as naloxone is given quickly [4]. MedlinePlus tells people taking tramadol to talk to their doctor about having naloxone at hand [2]. The label agrees that a reversal agent is given for clinically significant respiratory or circulatory depression [1]. Then it adds the caveat. A reversal agent will reverse some, but not all, of the symptoms of a tramadol overdose. The risk of seizures is also increased when one is given [1]. That is a reason to call 911 first and to have medical help on the way. It is not a reason to withhold naloxone from someone who is not breathing. The person giving it should expect that a seizure is possible. The emergency team will need to know tramadol was involved. Our page on Narcan covers the reversal drug itself.
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
Tramadol Withdrawal in Outline
Withdrawal is what physical dependence looks like when the drug stops. The label says both tolerance and physical dependence can develop during opioid therapy. Dependence may not reach a clinically significant degree until after several days to weeks of continued use [1]. Its instruction to prescribers is firm. Do not rapidly reduce or abruptly discontinue tramadol in a patient who is physically dependent [1]. Rapid tapering, the label says, may lead to serious withdrawal symptoms, uncontrolled pain and suicide [1]. When tramadol is discontinued, the label calls for a gradual, patient-specific plan built on the amount, the duration and the person [1]. No such plan is on this page.
MedlinePlus lists what withdrawal from tramadol feels like: nervousness, panic, sweating, trouble sleeping, runny nose, sneezing or cough, pain, hair standing on end, chills, nausea, uncontrollable shaking, diarrhea, or, rarely, hallucinations [2]. NIDA’s list is muscle and bone pain, cold flashes with goose bumps, cramps, diarrhea, involuntary leg movements, restlessness, vomiting and insomnia [4]. Panic and hallucinations are the two features on MedlinePlus’s list that NIDA’s list does not carry. The current FDA label cited here describes withdrawal in the standard opioid terms and does not use the word “atypical”, so this page does not either. MedlinePlus’s instruction matches the label’s. Do not stop taking tramadol without talking to your doctor [2].
Two facts from the federal guidance frame the danger correctly. SAMHSA’s detox protocol says that, unlike alcohol and sedative withdrawal, uncomplicated opioid withdrawal is not life-threatening. Rarely, it adds, severe vomiting or diarrhea can lead to dehydration or electrolyte imbalance [7]. The larger risk comes after. MedlinePlus says the biggest complication of opioid withdrawal is returning to the medicine. Most opioid overdose deaths occur in people who have just detoxed. Withdrawal lowers tolerance, so a much smaller amount than before can cause an overdose [8].
This page gives no onset, peak or duration for tramadol withdrawal. None of the federal sources cited here publishes a figure for the drug. Figures published for other opioids are not tramadol’s. Our page on tramadol withdrawal takes the course on its own. Our overview of withdrawal symptoms covers how this compares across substances.
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
How Long Tramadol Stays in Your System
This is a question people ask about every drug, and for tramadol the honest answer is that no federal table gives one.
What the label says. The mean terminal half-life of tramadol is about 6.3 hours, and that of its active metabolite M1 is about 7.4 hours [1]. With repeated dosing, the label says, tramadol’s half-life rose from approximately six hours to seven [1]. The drug is cleared mainly by the liver, and the metabolites leave through the kidneys. About 30 percent of a dose leaves in the urine unchanged and about 60 percent as metabolites [1]. A half-life is how long it takes the amount in the blood to fall by half. It is a property of the drug. It is not a detection window, and the two should not be confused.
What the federal tables say. The federal workplace drug-testing rule at 49 CFR 40.85 lists nine analyte groups that laboratories must test for. Tramadol is not among them [10]. SAMHSA’s table of urine detection periods in TIP 47 has rows for amphetamines, barbiturates, benzodiazepines, cocaine, cannabinoids, alcohol, methadone and others. Its opioids row names codeine and morphine. It has no row for tramadol [9]. SAMHSA’s detox protocol adds that the usual opioid tests mainly detect the opium-derived drugs. Special tests are ordered for synthetic opioids [7]. Tramadol is a synthetic. Special tests for it exist. What a particular program, employer or court uses is the thing to ask them.
What a window would depend on, if you had one. SAMHSA says the time a substance can be detected in urine depends on many interacting factors. It names the drug’s chemical properties such as its half-life, its metabolism and excretion routes, the amount, route, frequency and length of use, the sensitivity and specificity of the assay, and individual variation [9]. So this page prints no urine, blood, saliva or hair window for the drug. No federal source it can cite gives one.
Treatment for Tramadol Addiction
NIDA’s position on opioid addiction is specific. When treating addictions to opioids, medication should be the first line of treatment, usually combined with some form of behavioral therapy or counseling [11]. Methadone, buprenorphine and naltrexone are all FDA-approved medications to treat opioid use disorder. Lofexidine is an FDA-approved medication to reduce opioid withdrawal symptoms [4]. NIDA describes how the three work in one line each. Methadone is a full agonist that activates opioid receptors to ease withdrawal symptoms and cravings. Buprenorphine is a partial agonist that attaches to and partially activates those receptors. Naltrexone is an antagonist that prevents opioids from attaching to their receptors, blocking their effects [3]. The tramadol label adds one sequencing point a prescriber weighs. Partial agonists such as buprenorphine can set off withdrawal in a patient still receiving a full agonist [1]. Which medication, if any, when it starts, and at what amount are a prescriber’s decisions. Our overview of medication-assisted treatment explains how those medicines fit into a longer plan.
Behavioral therapies do the rest of the work. NIDA says they help people change their attitudes and behaviors around drug use, handle stress and triggers, and stay in treatment longer [11]. Cognitive-behavioral therapy helps people recognize, avoid and cope with the situations in which they are most likely to use. Contingency management uses rewards for staying drug-free and attending sessions. Motivational enhancement therapy works on readiness to change. Family therapy addresses the influences around a person’s use [11]. Our overview of the types of therapy and our page on cognitive behavioral therapy cover the same ground in more depth.
Detox is where many people start, and it is not where treatment ends. SAMHSA’s protocol says detoxification is not substance abuse treatment and rehabilitation. A detox program is not designed to resolve the longstanding psychological, social and behavioral problems associated with alcohol and drug use [12]. NIDA puts the consequence plainly. Detoxification alone, without subsequent treatment, generally leads to resumption of drug use [11]. MedlinePlus says most people need long-term treatment after detox. It also says anyone going through detox for opioids should be checked for depression and other mental illnesses [8]. Our page on medical detox explains what makes a detox medical and what has to follow it. Our guide to the levels of care sets out the five treatment levels that come after. Our page on inpatient rehab describes the most structured of them. Our page on outpatient rehab describes the lighter end.
The practical questions settle faster than people expect. Our page on how long rehab takes covers length of stay. Our page on how much rehab costs gives our own published price ranges by level of care. Our guide to insurance coverage covers what a plan decides. Our guide to the admissions process sets out what a program needs before it can give someone a date. Our page on what the rehab process is like walks through a stay. Our treatment center directory has a map you can browse by state.
Frequently Asked Questions
Is tramadol addictive? Yes. The FDA’s label carries a boxed warning that tramadol exposes users to the risks of addiction, abuse and misuse, which can lead to overdose and death, and it says addiction can occur even in patients who are prescribed it appropriately. MedlinePlus says tramadol may be habit forming, especially with prolonged use. NIDA says people who use tramadol may develop an opioid use disorder. Schedule IV is a legal category, not a safety rating.
Can tramadol cause seizures? Yes. The label says seizures have been reported in patients taking tramadol within the range it allows, and more often above it. The risk rises with SSRIs, tricyclic antidepressants, other opioids, MAO inhibitors and neuroleptics, and in people with epilepsy or other seizure risk factors. In an overdose, giving naloxone may also increase seizure risk. If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
Is tramadol a controlled substance? Yes. The DEA placed tramadol into Schedule IV of the Controlled Substances Act in a final rule published on July 2, 2014, effective August 18, 2014. The label describes it as a Schedule IV controlled substance, and the DEA’s scheduling page lists it there today with Xanax, Valium and Ambien. Before 2014 it was not federally scheduled.
What are the signs of a tramadol overdose? Slow or shallow breathing, extreme sleepiness progressing to stupor or coma, limp muscles, cold and clammy skin, constricted pupils, and sometimes seizures. Call 911 first. Naloxone reverses some but not all effects of a tramadol overdose and may raise the risk of a seizure, so the emergency team needs to know tramadol was involved. If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
How long does tramadol stay in your system? No federal table gives a window. The label reports a mean terminal half-life of about 6.3 hours for tramadol and 7.4 hours for its active metabolite, which is a property of the drug and not a test window. Tramadol is not among the nine analyte groups in the federal workplace testing rule and has no row in SAMHSA’s urine detection table, so this page prints no urine, blood or hair window. Specialized tests exist; ask the program or employer.
Sources
- U.S. Food and Drug Administration. (2025). TRAMADOL HYDROCHLORIDE tablets — Full Prescribing Information: Boxed Warning, Indications and Usage, Warnings and Precautions (Addiction, Abuse, and Misuse; Life-Threatening Respiratory Depression; Ultra-Rapid Metabolism of Tramadol in Children; Serotonin Syndrome Risk; Increased Risk of Seizure; Suicide Risk; Withdrawal), Drug Abuse and Dependence, Overdosage, Clinical Pharmacology (Mechanism of Action; Pharmacokinetics). DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e5005d9e-91cb-4ff8-bcf2-b5ee70cf4f3f
- U.S. National Library of Medicine. (2024). Tramadol. MedlinePlus Drug Information. https://medlineplus.gov/druginfo/meds/a695011.html
- National Institute on Drug Abuse. (2021). Prescription Opioids DrugFacts. National Institute on Drug Abuse. https://nida.nih.gov/publications/drugfacts/prescription-opioids
- National Institute on Drug Abuse. (2025). Drugs A to Z — Tramadol. National Institute on Drug Abuse. https://nida.nih.gov/research-topics/drugs-a-to-z
- Drug Enforcement Administration. (2014). Schedules of Controlled Substances: Placement of Tramadol Into Schedule IV — Final Rule, 79 FR 37623. Federal Register. https://www.federalregister.gov/documents/2014/07/02/2014-15548/schedules-of-controlled-substances-placement-of-tramadol-into-schedule-iv
- Drug Enforcement Administration. Drug Scheduling — Schedules I to V. U.S. Department of Justice. https://www.dea.gov/drug-information/drug-scheduling
- Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 4: Physical Detoxification Services for Withdrawal From Specific Substances — Opioids; Laboratory Tests. Substance Abuse and Mental Health Services Administration. https://www.ncbi.nlm.nih.gov/books/NBK64116/
- U.S. National Library of Medicine. (2026). Opiate and opioid withdrawal. MedlinePlus Medical Encyclopedia. https://medlineplus.gov/ency/article/000949.htm
- Center for Substance Abuse Treatment. (2006). Substance Abuse: Clinical Issues in Intensive Outpatient Treatment, TIP 47, Appendix B: Urine Collection and Testing Procedures and Alternative Methods for Monitoring Drug Use — Exhibit B-1. Substance Abuse and Mental Health Services Administration. https://www.ncbi.nlm.nih.gov/books/NBK64092/
- Legal Information Institute, Cornell Law School. 49 CFR § 40.85 — What are the cutoff concentrations for urine drug tests? Electronic Code of Federal Regulations. https://www.law.cornell.edu/cfr/text/49/40.85
- National Institute on Drug Abuse. (2020). Drugs, Brains, and Behavior: The Science of Addiction — Treatment and Recovery. National Institute on Drug Abuse. https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery
- Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 1: Overview, Essential Concepts, and Definitions in Detoxification. Substance Abuse and Mental Health Services Administration. https://www.ncbi.nlm.nih.gov/books/NBK64119/
This page is for general information and is not medical advice. Only a licensed clinician who
knows your history can tell you what is right for you. If you or someone you know is in
immediate danger, call 911. For free, confidential support 24/7, call or text 988.
Author
Chief Medical Officer,
The Recovery Village
